Invopharm

Invopharma provides fast-track market access to Rare Disease and specialty pharmaceutical companies looking to expand into the Middle East and North Africa (MENA region) Established in 2023, with a disruptive move to bring innovative treatment to MENA region as well as provide a high-quality first movers generics. Invopharma is based in the Dubai Science Park (DSP), U.A.E. It also has an office in Ontario, Canada and supported with local distributors in GCC countries. Operating through evidence-based medicine and the highest ethical standards, Invopharma provides its partners with fast and sustainable market access solutions into the MENA region. Invopharma employs highly qualified and experienced MSLs and KAMs. It offers regulatory, medical, PV and logistical support. Armed with knowledge of the local business culture and the vast network of trusted partners, Invopharma's expertise allows it to create market opportunities for innovative healthcare products and services.